FDA guidance targets biological indicators
Device Regulation Alert: Safety, Compliance and Reimbursement News, October 15, 2007
The FDA released guidance for premarket submissions of biological indicators (BI) that monitor sterilizers in healthcare facilities to prevent nosocomial infections.
The guidance applies to 510(k) submissions for Class II devices that monitor the adequacy of the sterilization processes. It does not address physical or chemical sterilization process indicators identified in 21 CFR 880.2800(b), BIs used in manufacturing, and BIs used in liquid chemical sterilization.
The guidance tells manufacturers to use a table to compare their new devices to devices already being legally marketed. The table should compare the devices' use (e.g. method of sterilization), organisms, resistance characteristics, viable spore population, and shelf-life. The guidance also recommends manufacturers give detailed descriptions of the device's design and manufacturing characteristics, address performance specifications, and demonstrate that the characteristics last throughout the device's shelf-life.
Click here to read the guidance on the FDA's Web site.
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched
